Home / Intelligence / Blog / Verily to Acquire SignalPath, Expanding the Company’s Clinical Research Capabilities
Published August 30, 2021

Verily recently announced its first major acquisition, a software platform known as SignalPath. SignalPath’s flagship software, TrialPath, digitizes and modulates individual protocols in a clinical trial, from budgeting to tracking point-of-care communication. The acquisition would fold SignalPath into Baseline, Verily’s clinical research platform designed to improve clinical trial execution, help research manage their clinical trials, and explore flexible study options for decentralized and hybrids trials as well as novel ways to capture real-world data (i.e., generated by novel sensors and biomarkers).
While many details of the agreement were not disclosed, including the financial terms, this deal could “set a new standard for clinical studies and evidence generation,” according to Amy Abernethy, MD, PhD, a former principal deputy commissioner at the FDA and current President of Clinical Studies Platforms at Verily. With a tech giant backing and a growing pipeline of digital technologies, including a virtual clinic that provides online care and coaching for chronic conditions, Verily can now use a new system to accelerate its research and trial processes, to quickly establish its presence in the DTx.
Written by Crystal Zhao and Kate Watkins
Related Intelligence
Webinars
IC Administration Simplified
March 5, 2025 | 12:00 – 12:30 PM ET
Are you ready to take a bite out of IC administration complexity? Nothing demotivates a sales team like delayed or inaccurate incentive compensation (IC) calculations and payouts. While administering an IC plan may seem simple to outsiders, seasoned IC administrators know that’s not the case. It takes laser-focused attention to detail and timeliness to manage […]
Sign Up Now
Blog
Are Pharma Brands Really Transformational?
How can pharma brands connect digital marketing experiences to achieve truly transformational customer engagement? Brands that are leading the way demonstrate a complete grasp of fundamental digital marketing concepts and drive innovation in the ways that they engage customers. These brands maintain consistency in their message and interactions but tailor them to customer specific needs—and […]
Read More
Webinars
Navigating the Early Asset Evaluation Journey with Confidence
February 25, 2025 | 1:00 – 1:45 PM ET
There is no room for missteps along the journey to evaluate the viability of assets in early stages of development. When making go/no go decisions, many critical questions must be answered across the early asset lifecycle. Join a team of cross-functional experts for a lively panel discussion on how to approach early commercial assessment with insight from various perspectives.
Sign Up Now